アラマー・バイオサイエンシズ
Alamar Biosciences, Inc.
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.22 | $29M | -$15M |
| 2026 Q1 | -0.31 | $26M | -$21M |